By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Rifampicin

Rifampicin

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
4 min read|712 words

Rifampicin Drug Profile

What is Rifampicin?

Rifampicin is an antibiotic medication that belongs to the rifamycin class of drugs. It is primarily used to treat tuberculosis and other mycobacterial infections, as well as certain bacterial infections including meningococcal disease. This medication is considered an essential medicine by the World Health Organization and plays a crucial role in tuberculosis treatment programs worldwide.

Uses

Rifampicin has several important medical applications:

Tuberculosis treatment: Rifampicin is a first-line medication for treating active tuberculosis, typically used in combination with other anti-TB drugs such as isoniazid, ethambutol, and pyrazinamide.

Latent tuberculosis infection: It may be prescribed to treat latent TB infections, often in combination with isoniazid, to prevent progression to active disease.

Submit Your Paper
GMJ_Submit_Banner

Atypical mycobacterial infections: The drug is effective against certain non-tuberculosis mycobacterial species that can cause lung, skin, or disseminated infections.

Meningococcal prophylaxis: Rifampicin is used to prevent meningococcal meningitis in close contacts of infected individuals.

Staphylococcal infections: In some cases, it may be used as part of combination therapy for serious staphylococcal infections, particularly those involving prosthetic devices or biofilms.

How it works

Rifampicin works by inhibiting bacterial RNA polymerase, an essential enzyme that bacteria need to produce RNA and synthesize proteins. By blocking this enzyme, the medication prevents bacteria from reproducing and ultimately leads to their death. This mechanism makes it particularly effective against mycobacteria, including the organisms that cause tuberculosis.

Side effects

Common side effects include:

  • Orange or red discoloration of urine, tears, sweat, and saliva
  • Nausea and vomiting
  • Loss of appetite
  • Diarrhea
  • Stomach upset or abdominal pain
  • Headache
  • Dizziness
  • Fatigue or weakness

Serious side effects to watch for:

  • Liver toxicity (hepatitis) – symptoms include yellowing of skin or eyes, severe fatigue, dark urine
  • Severe allergic reactions including rash, fever, or difficulty breathing
  • Blood disorders such as low platelet count or anemia
  • Kidney problems including acute kidney injury
  • Severe gastrointestinal symptoms including persistent vomiting or severe diarrhea

Warnings and precautions

Liver monitoring: Regular liver function tests are essential during treatment, as rifampicin can cause serious liver damage. Patients with existing liver disease require careful monitoring.

Pregnancy considerations: Rifampicin is generally considered safe during pregnancy for treating tuberculosis, but should only be used when the benefits outweigh potential risks and under medical supervision.

Alcohol use: Patients should avoid or limit alcohol consumption while taking rifampicin, as both substances can affect liver function and increase the risk of liver toxicity.

Contact lens wearers: The medication can permanently stain soft contact lenses orange-red, so patients should switch to glasses or daily disposable contacts during treatment.

Compliance importance: Incomplete treatment can lead to drug-resistant tuberculosis, making the infection much more difficult to treat and potentially life-threatening.

Interactions

Rifampicin has numerous significant drug interactions due to its effect on liver enzymes:

Oral contraceptives: Rifampicin can reduce the effectiveness of birth control pills, requiring alternative contraceptive methods during treatment.

Warfarin: The medication can decrease warfarin’s blood-thinning effects, requiring more frequent monitoring and dose adjustments.

Diabetes medications: It may reduce the effectiveness of certain diabetes drugs, potentially requiring dosage adjustments.

HIV medications: Many antiretroviral drugs have reduced effectiveness when taken with rifampicin, requiring careful drug selection and monitoring.

Immunosuppressive drugs: Medications like cyclosporine and tacrolimus may have reduced levels, affecting transplant patients or those with autoimmune conditions.

Antifungal medications: Certain antifungals like ketoconazole may have reduced effectiveness.

Heart medications: Some cardiac drugs including certain calcium channel blockers and digoxin may require dose adjustments.

Seizure medications: Anti-epileptic drugs may have altered levels, potentially affecting seizure control.

Check interactions with the GMJ Interaction Checker

Dosage

For tuberculosis treatment in adults, typical rifampicin dosages range from 450-600 mg once daily, depending on body weight. The medication is usually taken on an empty stomach, at least one hour before or two hours after meals for optimal absorption. Treatment duration varies but typically lasts 6-9 months for tuberculosis. For meningococcal prophylaxis, the usual adult dose is 600 mg twice daily for two days. Dosage should always be determined and monitored by a healthcare provider based on the specific condition being treated, patient weight, kidney and liver function, and other individual factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Rifampicin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/rifampicin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
E-cigarettes deliberately designed to target youth through availability and addictive features, researchers warn

New research reveals how tobacco companies systematically design e-cigarettes to maximize youth…

FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Amphotericin B

By
Prof. Giorgi Pkhakadze
02/06/2026

Goldenseal

By
Prof. Giorgi Pkhakadze
02/06/2026

Levetiracetam

By
Prof. Giorgi Pkhakadze
02/06/2026

Vitamin B9 (Folate)

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up